Scientists at a London hospital have successfully completed the world's first trial of a drug designed to reverse hearing loss. The REGAIN trial, at University College London Hospital (UCLH ...

Cancer patient's agonising death alone - after hospital moves him to a hotel to cut costs ...

A revolutionary new treatment called Targeted Thermal Therapy (Tripel T) offers a safer, faster alternative to surgery for patients with high blood pressure caused by Primary Aldosteronism, a hormonal ...

Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of ...

Acute hospital wards are facing "real challenges ... The research, led by a team from University College London (UCL), looked at data on all admissions for five to 18-year-olds to general ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

A revolutionary new treatment called Targeted Thermal Therapy (Tripel T) offers a safer, faster alternative to surgery for patients with high blood pressure caused by Primary Aldosteronism, a hormonal ...